Clinical Trial Update: Effect of a Continuous Infusion of Esmolol on Stroke Volume in Patients With Hyperdynamic Vasoplegic Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a continuous infusion of esmolol to affect stroke volume in hyperdynamic vasoplegic septic shock has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Esmolol (esmolol)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Shock, Septic | Phase 3 | Status: WITHDRAWN